Review
Published on 16 Jun 2023
The recent progress of peptide regulators for the Wnt/β-catenin signaling pathway
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1164656
- 5,697 views
- 9 citations
Type at least 3 characters
80 articles
Review
Published on 31 May 2023
A primer on in vivo cell tracking using MRI
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1193459
- 5,551 views
- 11 citations
Original Research
Published on 30 May 2023
Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1128295
- 9,639 views
- 16 citations
Original Research
Published on 25 May 2023
Prime editing strategies to mediate exon skipping in DMD gene
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1128557
- 6,905 views
- 9 citations
Original Research
Published on 09 May 2023
Uncovering transcriptomic landscape alterations of CAN-2409 in in vitro and in vivo glioma models
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1140352
- 4,301 views
- 2 citations
Correction
Published on 03 Mar 2023
Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1143748
- 1,876 views
Editorial
Published on 21 Feb 2023
Editorial: Global excellence in gene and cell therapy: Europe
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1154360
- 1,505 views
Review
Published on 17 Feb 2023
Anti-ROR1 CAR-T cells: Architecture and performance
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1121020
- 12,282 views
- 11 citations
Review
Published on 03 Feb 2023
AAV- based vector improvements unrelated to capsid protein modification
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1106085
- 18,861 views
- 11 citations
Review
Published on 19 Jan 2023
Barriers to Treg therapy in Europe: From production to regulation
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1090721
- 5,995 views
- 12 citations
Original Research
Published on 19 Jan 2023
Clinical experience: Outcomes of mesenchymal stem cell transplantation in five stroke patients
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1051831
- 6,532 views
- 12 citations
Original Research
Published on 13 Dec 2022
Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2022.1052318
- 5,370 views
- 11 citations
Original Research
Published on 08 Dec 2022
AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2022.1018208
- 2,515 views
- 3 citations
Original Research
Published on 29 Nov 2022
Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2022.939776
- 7,049 views
- 17 citations
Original Research
Published on 23 Nov 2022
Interaction between human leukocyte antigen (HLA-C) and killer cell Ig-like receptors (KIR2DL) inhibits the cytotoxicity of natural killer cells in patients with hepatoblastoma
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2022.947729
- 2,025 views
- 4 citations
Review
Published on 08 Nov 2022
The polymerase δ-interacting protein family and their emerging roles in diseases
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2022.1026931
- 3,349 views
- 2 citations